SigCharts

$MRK ELLIOTWAVES

Длинная
NYSE:MRK   Merck & Company, Inc.
My current waves on $MRK

would love some feedback, this catalyst and original chart was brought up originally by @tomikazi

It broke out of the downtrend channel and now is in wave 1.

Has a catalyst on Wednesday 1/20/21
PDUFA VII Decision for MRK's Vericiguat:

Merck Seeks Approval For Heart Failure Drug

Company: Merck & Co., Inc. (NYSE: MRK)
Type of Application: NDA
Candidate: vericiguat
Indication: heart failure

Positive ER expected:

Merck & Co., Inc.'s earnings, with the lowest EPS estimate coming in at $1.32 and the highest estimate coming in at $1.38. Merck & Co., Inc. reported
earnings of $1.16 per share during the same quarter last year, which indicates a positive year over year growth rate of 16.4%. The firm is scheduled to issue
its next quarterly earnings report before the market opens on Thursday, February 4th. -Marketbeat

Отказ от ответственности

Все виды контента, которые вы можете увидеть на TradingView, не являются финансовыми, инвестиционными, торговыми или любыми другими рекомендациями. Мы не предоставляем советы по покупке и продаже активов. Подробнее — в Условиях использования TradingView.